IPSC
Century Therapeutics, Inc. · Healthcare · Market cap $271.6M
Insiders sold $10K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 15, 2026
Insider Buying
$97K
reported purchases (SEC code P)
Insider Selling
$86K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 15, 2026
Russotti Gregory
Century Therapeutics, Inc. (IPSC) has 41 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 4 insiders at Century Therapeutics, Inc. reported 3 open-market purchases totaling $97K and 20 open-market sales totaling $86K. The most active filer is SVP Finance & Operations Carr Douglas with 11 filings. The most recent open-market filing is a sale of 2,587 shares by See Remarks Russotti Gregory, dated Sep 14, 2026, worth $5K.
- Industry:Biotechnology
- CEO:Brent Pfeiffenberger
- Employees:78
- HQ:Philadelphia, PA, US
- IPO:2021-06-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| See Remarks | Sale | 2,587 | $5K | Sep 15 | -24.2% | SEC ↗ | |
| SVP Finance & Operations | Sale | 1,658 | $3K | Sep 15 | -24.2% | SEC ↗ | |
| See Remarks | Sale | 534 | $1K | Sep 9 | -26.1% | SEC ↗ | |
| SVP Finance & Operations | Sale | 254 | $521 | Sep 9 | -26.1% | SEC ↗ | |
| SVP Finance & Operations | Sale | 275 | $544 | Aug 5 | -23.5% | SEC ↗ | |
| See Remarks | Sale | 2,584 | $6K | Jun 15 | -34.8% | SEC ↗ | |
| SVP Finance & Operations | Sale | 1,654 | $4K | Jun 15 | -34.8% | SEC ↗ | |
| See Remarks | Sale | 524 | $1K | Jun 9 | -32.1% | SEC ↗ | |
| SVP Finance & Operations | Sale | 249 | $526 | Jun 9 | -32.1% | SEC ↗ | |
| SVP Finance & Operations | Sale | 264 | $618 | May 6 | -35.9% | SEC ↗ | |
| SVP Finance & Operations | Sale | 7,043 | $18K | Mar 16 | — | SEC ↗ | |
| See Remarks | Sale | 10,076 | $26K | Mar 16 | — | SEC ↗ | |
Russotti GregoryFirst in 3 months | See Remarks | Sale | 479 | $1K | Mar 11 | — | SEC ↗ |
| SVP Finance & Operations | Sale | 247 | $626 | Mar 11 | — | SEC ↗ | |
| SVP Finance & Operations | Sale | 323 | $589 | Feb 5 | — | SEC ↗ | |
| Chief Scientific Officer | Purchase | 58,060 | $49K | Dec 29 | — | SEC ↗ | |
| President and CEO | Purchase | 52,000 | $30K | Dec 16 | — | SEC ↗ | |
Russotti GregoryFirst filing | See Remarks | Sale | 526 | $280 | Dec 10 | — | SEC ↗ |
| SVP Finance & Operations | Sale | 257 | $137 | Dec 10 | — | SEC ↗ | |
Cowan ChadFirst filing | Chief Scientific Officer | Sale | 5,462 | $3K | Nov 24 | — | SEC ↗ |
| President and CEO | Purchase | 35,000 | $17K | Nov 20 | — | SEC ↗ | |
Pfeiffenberger BrentFirst filing | President and CEO | Sale | 32,456 | $15K | Nov 19 | — | SEC ↗ |
Carr DouglasFirst filing | SVP Finance & Operations | Sale | 292 | $171 | Nov 5 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does IPSC have?
Century Therapeutics, Inc. (IPSC) has 41 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for IPSC?
The most recent Form 4 filing for IPSC on Tracefour is dated Sep 15, 2026.
Who is the most active insider at IPSC?
The most active SEC Form 4 filer at IPSC in the rolling window is SVP Finance & Operations Carr Douglas, with 11 filings.
What is the net insider flow at IPSC over the last 6 months?
Over the trailing 180 days, insiders at IPSC have net sold $22K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IPSC in the current window?
Inside the rolling window, insiders at IPSC bought $97K and sold $86K based on SEC Form 4 filings.
Can I get alerts for IPSC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Century Therapeutics, Inc. (IPSC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Century Therapeutics, Inc. is in the Healthcare sector.